These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 15969)

  • 61. Drugs for hypothyroidism and hyperthyroidism.
    Medical Letter, Inc
    Treat Guidel Med Lett; 2006 Apr; 4(44):17-24. PubMed ID: 16554701
    [No Abstract]   [Full Text] [Related]  

  • 62. Beta-adrenergic-antagonist therapy for hyperthyroid Graves' disease.
    Utiger RD
    N Engl J Med; 1984 Jun; 310(24):1597-8. PubMed ID: 6145094
    [No Abstract]   [Full Text] [Related]  

  • 63. [Advancement in preoperative treatment of patients with pheochromocytoma].
    Mićić R
    Srp Arh Celok Lek; 1969 Jan; 97(1):97-104. PubMed ID: 4392132
    [No Abstract]   [Full Text] [Related]  

  • 64. [Clinical pharmacology of beta-adrenoceptor blocking drugs and therapeutic use in hypertension (author's transl)].
    Ebihara A
    Nihon Naika Gakkai Zasshi; 1980 Mar; 69(3):297-312. PubMed ID: 6103912
    [No Abstract]   [Full Text] [Related]  

  • 65. [Differentiation with practolol of the type of beta adrenergic receptor involved in insulin secretion].
    Mariani MM; Loubatières A; Chapal J; Savi L; Sorel G
    C R Seances Soc Biol Fil; 1970; 164(7):1596-600. PubMed ID: 4396555
    [No Abstract]   [Full Text] [Related]  

  • 66. Human insulin secretion: as integrated approach.
    Porte D; Bagdade JD
    Annu Rev Med; 1970; 21():219-40. PubMed ID: 4913946
    [No Abstract]   [Full Text] [Related]  

  • 67. Interesting uses of beta blockers: 5 Beta blockers in thyrotoxicosis.
    Larkins RG; Heyma P
    Aust Fam Physician; 1981 Oct; 10(10):833-5. PubMed ID: 6118114
    [No Abstract]   [Full Text] [Related]  

  • 68. [Letter: Bupranolol, a beta-blocker acting on insulin secretion in obesity].
    Simonin R; San Marco JL; Imbert C
    Nouv Presse Med; 1974 Sep; 3(32):2025. PubMed ID: 4154434
    [No Abstract]   [Full Text] [Related]  

  • 69. Abnormal alpha-adrenergic mechanisms in diabetes mellitus.
    Robertson RP; Beiter HL; Porte D
    Lancet; 1973 Feb; 1(7799):370. PubMed ID: 4121958
    [No Abstract]   [Full Text] [Related]  

  • 70. [Current problems in the clinical use of beta-adrenergic system blockaders in endocrinology].
    Tikhonova EP; Rom-Bugoslavskaia ES; Levchenko TP
    Probl Endokrinol (Mosk); 1971; 17(1):109-15. PubMed ID: 4398763
    [No Abstract]   [Full Text] [Related]  

  • 71. [Beta-adrenergic blockaders in cardiology].
    Muniz M
    Arq Bras Cardiol; 1979 Oct; 33(4):283-92. PubMed ID: 44836
    [No Abstract]   [Full Text] [Related]  

  • 72. Adrenergic blocking agents.
    Filner B
    Clin Anesth; 1974; 10(1):111-42. PubMed ID: 4149700
    [No Abstract]   [Full Text] [Related]  

  • 73. [Beta blockade and diabetes mellitus].
    Lager I; Smith U
    Lakartidningen; 1981 Feb; 78(8):696-9. PubMed ID: 6110815
    [No Abstract]   [Full Text] [Related]  

  • 74. Beta-adrenergic blockade and endocrine disorders.
    Rastogi GK; Jayakumar RV
    J Assoc Physicians India; 1976 Nov; 24(11):767-73. PubMed ID: 15969
    [No Abstract]   [Full Text] [Related]  

  • 75.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 76.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 77.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 78.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 79.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 80.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.